To launch the eighth season of the Pituitary World News podcast, we welcome to our microphones, Brandy. Brandy has quite a story to tell us about her battle with Cushing’s disease and her diagnosis. Brandy is an American Sign Language (ASL) professional interpreter and an accomplished artist, blogger, and musician.  We caught up with Brandy a few days before the Holidays to chat about her experiences in what proved to be a very interesting chat.

In this podcast directed to physicians, Dr. Lewis Blevins shares his vast experience of 30 years treating patients with central hypothyroidism.

In the last podcast in the series on the drugs available to manage hypercortisolism, Dr. Blevins discusses mifepristone, trade name Korlym®.  

This is the fourth podcast in a series of five on medications to treat Cushing’s disease.  Today Dr. Blevins discusses Pasireotide, trade names Signifor and Signifor LAR.

Our third podcast in the series is on osilodrostat (trade name Isturisa®), a drug approved by the FDA in the US and the European Medicines Agency (EMA) to treat hypercortisolism in patients who are not candidates for surgery or those that surgery did not work.  In this podcast, Dr. BLevins takes us inside his clinical practice to share his experiences with the drug.

The second podcast in our series on the medical management of hypercortisolism focuses on the drug metyrapone. Dr. Blevins discusses the drug uses, how it works, and its side effects. 

Coming up next, a discussion on the drug Isturiza® (osilodrostat).

This is the first in our series of five podcasts on the medical management of Hypersortisolism due to Cushing's disease. Today Dr. Blevins discusses the drug Ketoconazole.

Today we welcome three renowned experts in the development of drugs to treat hypercortisolism. Dr. Blevins and I discuss their research, clinical trials, challenges, and opportunities for these essential medications that could immensely affect patient well-being and quality of life. This discussion touches on the fascinating details of hypercortisolism and the developments now and in the future.

November 1 is Acromegaly Day. In this Podcast, Dr. Blevins gives us a perspective of the last 30 years on the developments in this field. Like many other conditions, the advances in therapy, imaging, surgery techniques, diagnostic testing, and clinical knowledge have been nothing short of remarkable. The future looks bright with many initiatives and research on new drugs and therapies, but there is still much work to do.  

Last week we caught up with Risa in San Francisco, California. She was nearing 1,200 miles (1,931 kilometers) on her bicycle ride from Canada to Mexico to focus awareness of acromegaly and pituitary disease. We chatted at a cafe not far from the Golden Gate bridge about her experience and what it is like to undertake an effort like this one while managing a challenging disease like acromegaly. Not surprisingly the Fleet Week event in San Francisco created a few distractions as we were recording the podcast. When you hear it, you'll know why. Check out the ride's progress here, and on the Risa Unleashed page.